Real-world experience of atezolizumab and bevacizumab for treatment of advanced hepatocellular carcinoma in a single tertiary center

被引：0
|
作者：
Raharjo, C. V. [1 ]
Joseph, R. [1 ]
Stratton, E. [1 ]
Levy, M. [1 ,2 ]
Prakoso, E. [1 ,3 ]
机构：
[1] Liverpool Hosp, Dept Gastroenterol, Liverpool, England
[2] Univ New South Wales, Sydney, Australia
[3] Univ Sydney, Sydney, NSW, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
106
引用
下载
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [21] Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian Center
    Ng, Kennedy Yao Yi
    Wong, Lawrence Wen Jun
    Ang, Andrea Jing Shi
    Tan, Sze Huey
    Choo, Su Pin
    Tai, David Wai-Meng
    Lee, Joycelyn Jie Xin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (05) : E249 - E261
  • [22] CHILD-PUGH CLASS DETERMINES THE OUTCOME OF PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH ATEZOLIZUMAB AND BEVACIZUMAB-A REAL-WORLD EXPERIENCE
    Kulkarni, Anand V.
    Krishna, Vamshi
    Patodiya, Bharat
    Shaik, Sameer
    Khan, Arif
    Sharma, Mithun
    Da, Pramod K.
    Reddy, Nageshwar D.
    Rao, Padaki Nagaraja
    HEPATOLOGY, 2022, 76 : S1435 - S1435
  • [23] Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study
    Chon, Young Eun
    Kim, Dong Yun
    Kim, Mi Na
    Kim, Beom Kyung
    Kim, Seung Up
    Park, Yong
    Ahn, Sang Hoon
    Ha, Yeonjung
    Lee, Joo Ho
    Lee, Kwan Sik
    Kang, Beodeul
    Kim, Jung Sun
    Chon, Hong Jae
    Kim, Do Young
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (03)
  • [24] Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice
    Yuka Hayakawa
    Kaoru Tsuchiya
    Masayuki Kurosaki
    Yutaka Yasui
    Shun Kaneko
    Yuki Tanaka
    Shun Ishido
    Kento Inada
    Sakura Kirino
    Koji Yamashita
    Tsubasa Nobusawa
    Hiroaki Matsumoto
    Tatsuya Kakegawa
    Mayu Higuchi
    Kenta Takaura
    Shohei Tanaka
    Chiaki Maeyashiki
    Nobuharu Tamaki
    Hiroyuki Nakanishi
    Jun Itakura
    Yuka Takahashi
    Yasuhiro Asahina
    Ryuichi Okamoto
    Namiki Izumi
    Investigational New Drugs, 2022, 40 : 392 - 402
  • [25] Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice
    Hayakawa, Yuka
    Tsuchiya, Kaoru
    Kurosaki, Masayuki
    Yasui, Yutaka
    Kaneko, Shun
    Tanaka, Yuki
    Ishido, Shun
    Inada, Kento
    Kirino, Sakura
    Yamashita, Koji
    Nobusawa, Tsubasa
    Matsumoto, Hiroaki
    Kakegawa, Tatsuya
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Tamaki, Nobuharu
    Nakanishi, Hiroyuki
    Itakura, Jun
    Takahashi, Yuka
    Asahina, Yasuhiro
    Okamoto, Ryuichi
    Izumi, Namiki
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (02) : 392 - 402
  • [26] Real-world outcomes of patients with advanced-stage hepatocellular carcinoma receiving combination therapy with atezolizumab and bevacizumab: A South Australian statewide experience
    Chan, A.
    Saluja, H.
    Nind, G.
    Singhal, N.
    Roy, A.
    Mcgregor, M.
    Chinnaratha, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 56 - 57
  • [27] Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications
    Lee, Cha Len
    Freeman, Mark
    Burak, Kelly W.
    Moffat, Gordon T.
    O'Donnell, Conor D. J.
    Ding, Philip Q.
    Lyubetska, Hanna
    Meyers, Brandon M.
    Gordon, Vallerie
    Kosyachkova, Ekaterina
    Bucur, Roxana
    Cheung, Winson Y.
    Knox, Jennifer J.
    Tam, Vincent C.
    CANCERS, 2024, 16 (16)
  • [28] Efficacy and safety of atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma in the real world: a single-arm meta-analysis
    Xiaoqiang Gao
    Rui Zhao
    Huaxing Ma
    Shi Zuo
    BMC Cancer, 23
  • [29] Efficacy and safety of atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma in the real world: a single-arm meta-analysis
    Gao, Xiaoqiang
    Zhao, Rui
    Ma, Huaxing
    Zuo, Shi
    BMC CANCER, 2023, 23 (01)
  • [30] ATEZOLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): REAL-WORLD EXPERIENCE FROM A US COMMUNITY ONCOLOGY NETWORK
    Cosgrove, David
    Tan, Amie
    Hernandez, Sairy
    Mahrus, Sami
    Osterland, Andrew
    Murphy, John
    Loaiza-Bonilla, Arturo
    HEPATOLOGY, 2022, 76 : S1308 - S1309
12345